Professional Documents
Culture Documents
DEFINITION (WHO):-
Oral submucous fibrosis (OSF) is a slowly progressive
chronic
fibrotic disease of the oral cavity and oropharynx,
characterized by fibroelastic changes and
inflammation of the mucosa, leading to a progressive
inability to open the mouth, swallow, or speak.
ETIOPATHOGENESIS:-
-OSF is regarded as a premalignant condition, and
many cases of oral cancer have been found
coexisting with submucous fibrosis.
-Primary factor
The habitual use of betel and its constituents, which
include:
The nut of the areca palm (Areca catechu).
The leaf of the betel pepper (Piper betle).
Lime (calcium hydroxide).
• These reactions may be the result of either direct
stimulation from exogenous antigens like Areca
alkaloids or changes in tissue antigenicity that
may lead to an autoimmune response.
• It occurs almost exclusively in inhabitants of
Southeast Asia, especially the Indian
subcontinent.
• The inflammatory response releases cytokines
and growth factors that promote fibrosis by
inducing the proliferation of fibroblasts, up-
regulating collagen synthesis and down-
regulating collagenase production.
CLINICAL FEATURES :-
Prodromal Symptoms(Early OSF):
Advanced Symptoms:-
• The mucosa appears blanched and opaque with
the appearance of fibrotic bands that can easily
be palpated.
• The bands usually involve the buccal mucosa,
soft palate, posterior pharynx, lips, and tongue.
• Gradually, patients develop a stiffening of the
mucosa,
with a dramatic reduction in mouth opening and
with difficulty in swallowing and speaking.
HISTOLOGIC EXAMINATION:
• Reveals severely atrophic epithelium with
complete loss of rete ridges.
• Varying degrees of epithelial atypia may be
present.
• The underlying lamina propria exhibits severe
hyalinization, with homogenization of collagen.
• Cellular elements and blood vessels are greatly
reduced.
MANAGEMENT:-
• The reduction or even elimination of habit of
arecanut chewing.
• Nutritional support: - high protein and calories,
for vitamin B complex and other vitamins and
minerals.
• Immunomodulatory Drugs: - Local and systemic
applications of glucocorticoids.
• Physiotherapy: - Measures such as forceful
mouth opening and heat therapy.
• Local Drug Delivery: - Submucosal injected
steroids and hyaluronidase, oral iron
preparations, and topical vitamin A and steroids
are some of the agents that are used.
• In severe cases, surgical intervention is the only
treatment:- Measures such as forcing the mouth
open and cutting the fibrotic bands have been
used, but it can cause more fibrosis and
disability.
PROGNOSIS: -
-The use of an oral stent as an adjunct to surgery to
prevent relapse has also been studied.
REFERENCES
-SHAFER’S TEXTBOOK OF ORAL PATHOLOGY 5TH
EDITION.
-BURKET’S ORAL MEDICINE, DIAGNOSIS &
TREATMENT 10TH EDITION.